174 related articles for article (PubMed ID: 23446753)
1. Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells.
Du Q; Hu B; An HM; Shen KP; Xu L; Deng S; Wei MM
Oncol Rep; 2013 May; 29(5):1851-8. PubMed ID: 23446753
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC
Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421
[TBL] [Abstract][Full Text] [Related]
3. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
Wu SJ; Ng LT; Lin CC
Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression.
Chen S; Xiao X; Feng X; Li W; Zhou N; Zheng L; Sun Y; Zhang Z; Zhu W
J Nutr Biochem; 2012 Sep; 23(9):1100-12. PubMed ID: 22137261
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells.
Chang PY; Peng SF; Lee CY; Lu CC; Tsai SC; Shieh TM; Wu TS; Tu MG; Chen MY; Yang JS
Int J Oncol; 2013 Oct; 43(4):1141-50. PubMed ID: 23917396
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.
Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK
Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
[TBL] [Abstract][Full Text] [Related]
8. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.
Wu SH; Hang LW; Yang JS; Chen HY; Lin HY; Chiang JH; Lu CC; Yang JL; Lai TY; Ko YC; Chung JG
Anticancer Res; 2010 Jun; 30(6):2125-33. PubMed ID: 20651361
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
Shi RX; Ong CN; Shen HM
Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effect of resveratrol in pancreatic cancer cells.
Cui J; Sun R; Yu Y; Gou S; Zhao G; Wang C
Phytother Res; 2010 Nov; 24(11):1637-44. PubMed ID: 21031621
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of resveratrol and paclitaxel on lung cancer cells.
Kubota T; Uemura Y; Kobayashi M; Taguchi H
Anticancer Res; 2003; 23(5A):4039-46. PubMed ID: 14666716
[TBL] [Abstract][Full Text] [Related]
12. Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression.
Wang W; Sun Y; Li X; Li H; Chen Y; Tian Y; Yi J; Wang J
Oncol Rep; 2011 Nov; 26(5):1143-8. PubMed ID: 21769433
[TBL] [Abstract][Full Text] [Related]
13. SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
Huang A; Yue D; Liao D; Cheng L; Ma J; Wei Y; Tong A; Cheng P
Oncol Rep; 2016 Dec; 36(6):3283-3290. PubMed ID: 27748945
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
15. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.
Cheng SB; Wu LC; Hsieh YC; Wu CH; Chan YJ; Chang LH; Chang CM; Hsu SL; Teng CL; Wu CC
J Agric Food Chem; 2012 Sep; 60(38):9620-30. PubMed ID: 22946656
[TBL] [Abstract][Full Text] [Related]
16. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.
Sun CY; Hu Y; Guo T; Wang HF; Zhang XP; He WJ; Tan H
Acta Pharmacol Sin; 2006 Nov; 27(11):1447-52. PubMed ID: 17049120
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of Bax and endonuclease G, and down-modulation of Bcl-XL involved in cardiotoxin III-induced apoptosis in K562 cells.
Yang SH; Chien CM; Lu MC; Lin YH; Hu XW; Lin SR
Exp Mol Med; 2006 Aug; 38(4):435-44. PubMed ID: 16953123
[TBL] [Abstract][Full Text] [Related]
19. Contribution of reactive oxygen species and caspase-3 to apoptosis and attenuated ICAM-1 expression by paclitaxel-treated MDA-MB-435 breast carcinoma cells.
Fawcett H; Mader JS; Robichaud M; Giacomantonio C; Hoskin DW
Int J Oncol; 2005 Dec; 27(6):1717-26. PubMed ID: 16273228
[TBL] [Abstract][Full Text] [Related]
20. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
